drugset / Trial / NCT05348200
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
RandomizedParallel-groupTriple-blindTreatment
Summary
A Randomized Phase 2 double blind study which aims to determine the safety and efficacy of CITI-002 cream in adult patients with Goligher's grade II or III hemorrhoids.
Timeline
- Start
- 2022-04-22
- Primary completion
- 2023-04-20
- Completion
- 2023-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | — | Topical |
| Comparator | halobetasol propionate | Small molecule | — | Topical |